Cite
MLA Citation
S Delaloge et al.. “Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial.” Annals of oncology, vol. 30, 2019, pp. 567–574. http://access.bl.uk/ark:/81055/vdc_100094062709.0x000033